Search
Search Results
##search.searchResults.foundPlural##
-
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2458PDF: 875HTML: 2464 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1672PDF: 1250HTML: 266 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4422PDF: 1727HTML: 1048 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
505PDF: 255HTML: 79 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1319PDF: 477HTML: 18616Figure 1: 174Figure 2: 154Figure 3: 171Figure 4: 210Figure 5: 182 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
3590PDF: 1086HTML: 880 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1999PDF: 778HTML: 702 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3949PDF: 1495HTML: 8520 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4023PDF: 1060HTML: 3604Untitled: 178Cneo. Fig.1: 115Untitled: 108Untitled: 129Untitled: 135 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2248PDF: 824HTML: 1638Figure 1: 195Table 1: 217 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1594PDF: 406HTML: 218 -
SOLITARY PLASMACYTOMA
3922PDF: 2206HTML: 1244fIGURES 1,2: 227 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7879PDF: 729HTML: 222 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2583PDF: 1173HTML: 145 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2606PDF: 815HTML: 5231 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3737PDF: 1120HTML: 2365Figure 1: 211 -
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients
1218PDF: 798HTML: 223 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2202PDF: 1618HTML: 315 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3211PDF: 1857HTML: 3673 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
1009PDF: 369HTML: 208 -
QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
1416PDF: 694HTML: 1382cover letter: 215 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2320PDF: 1340HTML: 17096Bassan Fig.1: 147Bassan Fig.2: 160Bassan Fig.4: 142Fig.3: 196 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2006PDF: 735HTML: 688Table1: patient's characteristics: 160Table 2: profile of each patient: 184 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1053PDF: 945Suppl. Files: 596HTML: 90







